70842-140 : Orbactiv 400 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 70842-140
Labeler: Melinta Therapeutics, Inc.
Product Type: Human Prescription Drug
Drug Name:  Orbactiv
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA206334
Rev. Date: 


NDC Package Codes:

  • 70842-140-03: 3 VIAL, GLASS IN 1 CARTON (70842‑140‑03) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, GLASS (70842‑140‑01)

Active Ingredients:

  • Oritavancin

Dosage Strength:

  • 400 mg

Pharmaceutical Classes:

  • Cytochrome P450 2C19 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inhibitors [MoA]
  • Cytochrome P450 2D6 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Lipoglycopeptide Antibacterial [EPC]
  • Lipoglycopeptides [CS]

Related Products:

Based on records with the same trade name.
  • 65293-015 Orbactiv 400 mg Intravenous Injection, Powder, Lyophilized, for Solution by The Medicines Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70842-140 QR Code

< Prev: 70842-120Next: 70842-160 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.